EdgarLookup

Spero Therapeutics, Inc. — All Filings

488 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 4 424B4 424B5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 FORM 4 SUBMISSION 0000899243-18-019568 Jul 6, 2018 Jul 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-019567 Jul 6, 2018 Jul 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-019566 Jul 6, 2018 Jul 5, 2018
8-K FORM 8-K 0001193125-18-188029 Jun 8, 2018 Jun 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-015330 Jun 6, 2018 Jun 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-015329 Jun 6, 2018 Jun 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-015328 Jun 6, 2018 Jun 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-015327 Jun 6, 2018 Jun 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-015326 Jun 6, 2018 Jun 5, 2018
4 FORM 4 SUBMISSION 0000899243-18-015325 Jun 6, 2018 Jun 5, 2018
DRS 0000950123-18-005976 May 25, 2018
8-K 8-K 0001193125-18-159225 May 10, 2018
10-Q SPERO THERAPEUTICS, INC. Q1 2018 10-Q 0001564590-18-012933 May 10, 2018 Mar 31, 2018
DEF 14A DEF14A 0001193125-18-136751 Apr 27, 2018 Jun 5, 2018
8-K 8-K 0001193125-18-104993 Apr 2, 2018
10-K 10-K 0001564590-18-007402 Apr 2, 2018 Dec 31, 2017
4 FORM 4 SUBMISSION 0000899243-18-008989 Mar 30, 2018
SC 13D SC 13D 0001144204-18-014661 Mar 14, 2018
SC 13G SC 13G 0001144204-18-009009 Feb 14, 2018
SC 13G SC 13G 0001719755-18-000003 Feb 14, 2018
SC 13G SC 13G 0001193125-18-043019 Feb 14, 2018
SC 13G SC 13G 0001104659-18-008815 Feb 13, 2018
SC 13G 0000315066-18-001574 Feb 13, 2018
3 FORM 3 SUBMISSION 0000899243-18-002991 Feb 6, 2018 Feb 1, 2018
8-K 8-K 0001193125-18-028379 Feb 1, 2018
8-K 8-K 0001193125-18-016749 Jan 23, 2018 Jan 17, 2018
4 FORM 4 SUBMISSION 0000899243-18-000561 Jan 5, 2018 Jan 4, 2018
3 FORM 3 SUBMISSION 0000899243-18-000560 Jan 5, 2018 Jan 4, 2018
4 FORM 4 SUBMISSION 0000899243-17-028851 Dec 15, 2017 Dec 13, 2017
4 FORM 4 SUBMISSION 0000899243-17-028850 Dec 15, 2017 Dec 13, 2017
4 FORM 4 SUBMISSION 0000899243-17-028848 Dec 15, 2017 Dec 13, 2017
4 FORM 4 SUBMISSION 0000899243-17-028846 Dec 15, 2017 Dec 13, 2017
S-8 FORM S-8 0001193125-17-369542 Dec 14, 2017
8-K 8-K 0001193125-17-369517 Dec 14, 2017
10-Q FORM 10-Q 0001193125-17-369457 Dec 14, 2017 Sep 30, 2017
SC 13G THE SCHEDULE 13G 0000921895-17-002581 Nov 9, 2017
4 FORM 4 SUBMISSION 0000899243-17-025510 Nov 7, 2017 Nov 6, 2017
4 FORM 4 SUBMISSION 0000899243-17-025508 Nov 7, 2017 Nov 6, 2017
4 FORM 4 SUBMISSION 0000899243-17-025507 Nov 7, 2017 Nov 6, 2017
4 FORM 4 SUBMISSION 0000899243-17-025506 Nov 7, 2017 Nov 6, 2017
4 FORM 4 SUBMISSION 0000899243-17-025505 Nov 7, 2017 Nov 6, 2017
8-K FORM 8-K 0001193125-17-334318 Nov 6, 2017
UPLOAD 0000000000-17-039167 Nov 6, 2017
424B4 424B4 0001193125-17-331186 Nov 2, 2017
EFFECT 9999999995-17-002842 Nov 1, 2017
3 FORM 3 SUBMISSION 0000899243-17-025160 Nov 1, 2017
3 FORM 3 SUBMISSION 0000899243-17-025158 Nov 1, 2017
3 FORM 3 SUBMISSION 0000899243-17-025153 Nov 1, 2017
3 FORM 3 SUBMISSION 0000899243-17-025151 Nov 1, 2017
3 FORM 3 SUBMISSION 0000899243-17-025146 Nov 1, 2017